Future of the Veterinary Vaccines Market: Trends, Innovations, and Key Forecasts Through 2034

"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Veterinary Vaccines Market Size By 2025?
The size of the veterinary vaccines market has shown significant growth in the past few years. Growth predictions indicate an increase from $13.56 billion in 2024 to $14.52 billion in 2025, marking a compound annual growth rate (CAGR) of 7.1%. The surge observed in the historical period is a result of the growth in emerging markets, a rise in spending on pets, increasing prevalence of diseases, more frequent outbreaks of poultry-related diseases, and a heightened occurrence of zoonotic diseases.

How Big Is the Veterinary Vaccines Market Size Expected to Grow by 2029?
Anticipated robust growth in the veterinary vaccines market is expected to push its size to $19.4 billion by 2029 at a compound annual growth rate (CAGR) of 7.5%. This growth trajectory in the forecast period can be linked to factors such as economic advancement, a surge in pet insurance adoption, escalation in pet ownership, increased governmental initiatives, and heightened consciousness about animal health. The upcoming trends for the forecast period entail investment in nanoparticle development, amplification in the production of subunit and virus-like particle-based vaccines and vaccines like parvovirus, distemper, and adenovirus which are fundamental to the regular vaccination regime of pet owners. A surge in investment in technological breakthroughs, an increase in funding for toxoid vaccines, a concentration on escalating investment on mRNA vaccines, and strategic alliances and partnerships are also expected.

View the full report here:
https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Which Key Market Drivers Powering Veterinary Vaccines Market Expansion and Growth?
The burgeoning number of animals grappling with various diseases is escalating the need for vaccines, designed to both prevent and cure such ailments. This adds impetus to the veterinary vaccines market. A report by the Animal and Plant Health Agency indicated that a total of 3289 new TB herd incidents were identified in England. Bovine tuberculosis is a progressive disease generally impacting cattle and other mammals, triggering a general state of sickness, cough, and ultimately leading to death. Yet, the ailment can be addressed using specific antibiotics that eradicate the TB bacteria. This surge in animal diseases is projected to stimulate the growth of the veterinary vaccines market during the predicted timeline.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2456&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Veterinary Vaccines Market?
Companies operating in the veterinary vaccines market are increasingly opting for strategic partnerships and collaborations to expand their presence in new markets and for joint research and development initiatives. For instance, Merck Animal Health, a US-based pharmaceutical firm, entered a four-year strategic alliance with the US-based research university, Iowa State University, in February 2022. This partnership aims to enable development of innovative solutions for animal health and covers various aspects including research and development, manufacturing, exploration of new technologies, business expansion, and others. The primary goal is to develop ingenious ways to meet animal health issues within the US as well as globally. Similarly, MSD Animal Health, a division of Merck & Co in the US, began a strategic partnership with Vinovo. This alliance is anticipated to allow MSD Animal Health to integrate their vast vaccine product line with Vinovo's vaccine delivery system, thus enhancing bird welfare and reduce vaccine reactions. Moreover, Wageningen bio veterinary research formed a strategic alliance with Switzerland-based Ceva, to advance their research in addressing the global threat of emerging and reemerging diseases for animals.

What Are the Emerging Segments in the Veterinary Vaccines Market?
The veterinary vaccines market covered in this report is segmented -

1) By Application: Livestock Vaccines, Companion Animal Vaccines
2) By Vaccine Type: Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other Vaccine Types
3) By Disease Type: Anaplasmosis, Canine Parvovirus, Foot And Mouth Disease, Newcastle Disease, Distemper Disease, Influenza, Porcine Reproductive And Respiratory Syndrome (PRRS)

Subsegments:
1) By Livestock Vaccines: Bovine Vaccines, Poultry Vaccines, Porcine Vaccines, Small Ruminant Vaccines (Sheep and Goats), Aquaculture Vaccines
2) By Companion Animal Vaccines: Canine Vaccines, Feline Vaccines, Equine Vaccines

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2456&type=smp

Who Are the Global Leaders in the Veterinary Vaccines Market?
Major companies operating in the veterinary vaccines market include Zoetis Inc., Boehringer Ingelheim GmbH, Merck & Co. Inc., Elanco Animal Health Incorporated, Ceva Santé Animale., Virbac Group, HIPRA, Biogenesis Bago, Kyoritsu Seiyaku Corporation, Phibro Animal Health Corporation, Century Vaccines Limited, Bayer Animal Health, Cadila Vaccines Ltd., Cargill India Pvt. Ltd., China Animal Healthcare Ltd., Jurox Pty Ltd, Nimrod Veterinary Products Ltd., Bimeda, Animalcare, MSD Animal Health, Interfeed, Biotex Plus Ltd., Belfarmacom, IDT Biologika, UCBVET, Lemavet, Syntec, Sauvet, Vetanco, Chemo Argentina, Brouwer, Agrovet Market Animal Health, DBK Pharma S.A.E.

Which are the Top Profitable Regional Markets for the Veterinary Vaccines Industry?
North America was the largest region in the veterinary vaccines market in 2024. Asia-Pacific was the second-largest region in the global veterinary vaccines market analysis. The regions covered in the veterinary vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2456

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Contact Us:
The Business Research Company
Europe - +44 7882 955267
Asia: +91 88972 63534
Americas - +1 310-496-7795
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company provides in-depth research and insights through a vast collection of 15,000+ reports spanning 27 industries and over 60 geographies. Backed by 1,500,000 datasets, extensive secondary research, and expert insights from industry leaders, we equip you with the knowledge needed to stay ahead in the market.

Our flagship offering, the Global Market Model, is a leading market intelligence platform that delivers comprehensive and up-to-date forecasts to support strategic decision-making.

This release was published on openPR.